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The meeting point of marine biology  
and marine pharmacology
Oceans include the most impressive and bizarre forms 
of life. The first living cell probably arose from the 
oceans, developed from a mono-cellular algae. They 
abound in a variety of plants with extraordinary and 
surprising features that are still obscure. Marine Bi-
ology studies every living thing in the depths of the 
ocean. These marine living resources are examined 
thoroughly for their unique properties.
Marine pharmacology is a brand new area of phar-
macology. It examines the pharmacological properties 
of substances and compounds extracted from marine 
plants and animals. Novel drugs were implemented 
with the assistance this new field. The meeting point of 
marine biology and marine pharmacology starts here: 
Marine biology describes and analyses the behavior, 
morphology and features of each plant and animal, 
whether marine pharmacology moves one step for-
ward, following the observed extracts, implementing 
and studying chemical complex substances for novel 
drug discoveries. Targeting at human diseases, there is 
a collaboration between marine biologists and marine 
pharmacologists.
The importance of identification and use of these 
substances from marine plants and animals is huge. 
There are many compounds of organisms still un-in-
vestigated by scientists for their precious pharmaco-
logical properties. Research is going on in this area for 
future promising substances.
In track to find the suitable treatment  
for osteoporosis
Nowadays there is a great interest in finding the suit-
able treatment for osteoporosis. Back in the 1980’s a 
novel class of compounds called SERMs (Selective 
Estrogen Receptor Modulators) brought a revolution 
in the way we think about osteoporosis management. 
In molecular level there are two major strategies: (a) 
promote bone formation by inducing osteoblast acti-
vation and (b) reduce bone resorption with prevention 
of osteoclasts activity (Figure 1). The main represen-
tatives of SERMs class of drugs are the newest raloxi-
fene and the oldest - prototype SERM called tamoxi-
fene. SERMs can be used in a treatment scheme in 
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post-menopausal osteoporosis with positive effects on 
BMD (bone mineral density) and reduction of fracture 
risk (hip and vertebrae)1,2 (Figure 2). New substances 
that are used in the battle against osteoporosis include 
bisphosphonates, strondium renolate and teriparatide 
[human recombinant PTH(1-34)]2. The need for per-
sonalized aspect in the treatment of osteoporosis in-
cluding the prevention of age bone loss in high risk 
groups lead to a new way of thinking. One of the main 
observations in epidemiological studies was that Asian 
women have less risk of osteoporosis than Caucasian 
ones. Nutrition is a factor that plays role in prevention 
and probably in treatment of bone loss with age.
Through historical textbooks there are indications 
about the extracts of several plants that have selective 
estrogenic properties and are called phytoestrogens. 
According to experimental models and epidemiologi-
cal studies phytoestrogens (isoflavones) improve bone 
mineral density, bone formation and biochemical 
markers, targeting at both genomic and non-genomic 
pathway3 (Figure 3). Under this spectrum marine phar-
macology tries to find nutritional factors from marine 
plants that prevent bone loss with increasing age.
The secrets of marine algae
Marine algae can be strong candidates for the extrac-
tion and implementation of novel drugs. Microscopic 
algae are called phytoplankton and macroscopic ones 
seaweeds. Although people come in contact with them 
when they are washed ashore, seaweeds are continu-
ously bathed in nutrient rich seawater, absorbing a 
high level of nutrients. Approximately 90% of the 
species of marine plants are algae and 50% of total 
photosynthesis is algal derived. They are one of the 
oldest family of plants on earth, flexible and prolific. 
They have a balance of essential amino acids and, 
surprisingly, are widely used directly or in most cases 
indirectly in dietary supplements, cosmetics, dairy 
products, industrial products etc4.
Already the importance of seaweed was well known 
from 300 BC in China and Japan, two countries that 
are major seaweed cultivators, producers and consum-
ers. Extracts of marine algae have been studied over 
the past years. They possess some important biologi-
cal activities which have medicinal value. Extracts of 
particular brown and blue-green seaweeds may have 
anti-tumor activity, anticholesterolemic activity (ste-
Figure 1. Drugs targeting into two levels: stimulation of 
bone formation and inhibition of resorption. Modern agents 
that are under experimental research concentrate on biomole-
cules that regulate osteoporosis progress (by International 
Osteoporosis Foundation tool kit series).
Figure 2. Chemical formula of (a) tamoxifen and 
(b) raloxifene.
Figure 3. Genistein is a promising phytoestrogen for osteo-
porosis management.
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rols and related compounds), antioxidant activity (as a 
photosynthetic plant, seaweed exposure to a combina-
tion of light and high oxygen concentrations lead to 
the production of free radicals), anticoagulant activity, 
antiviral activity, antihelminthic activity etc4-7.
Generally all seaweeds offer high concentrations 
of potassium in blood, similar to plasma levels, which 
results in lower average systolic pressure and lower 
risk of hypertension4.5. In laboratory animal studies 
using streptozotocin-induced diabetic rats, oral ad-
ministration decreased serum glucose and triglyceride 
levels4,5,8,9. Surprisingly two Japanese surgeons used a 
novel technique of mixing seaweed compounds with 
water to substitute whole blood in transfusion, a tech-
nique that was successfully tried in more than 100 op-
erations. Moreover marine algae are widely used for 
their seaweed extract polymer in pharmacy, biochem-
istry and medicine. «Jelly capsules» made by seaweed 
alginic acid are just the beginning, because these cap-
sules protect the compound e.g. insulin for diabetic 
patients from white blood cells and immune system. 
Alginates derived from seaweed have a soothing and 
cleansing effect on the digestive tract of human or-
ganism, sulphated polysaccharides used as films may 
be placed between gaps of bones so as to accelerate 
the growth of connective tissue. These may be used 
in arthritis treatment as healers of arthric surfaces4,7 
(Table 1).
Εxtracts derived from marine algae  
and bone metabolism
One of the most well searched alga is Padina Pavon-
ica. It is a brown alga of the Pheophycaeae family, in 
the order of Dictyotales, and grows in the Mediterra-
nean. The morphology of the alga is quite particular. It 
has a white-crystal colour because it deposits calcium 
carbonate outside its body, in the form of aragonite 
crystals. This is formed under the action of specific bi-
ological agents and pressure10-12 (Figure 4). The active 
principal called EPP (Extract of Padina Pavonica) is 
the main ingredient of dictyol, a dietary supplement 
against osteoporosis. Dictyol is in the form of hard-
gel capsule with 200 mg of dry EPP, with daily dos-
age of one capsule per os. It has been demonstrated 
by various studies that the extract of Padina Pavonica 
increases the uptake and fixation of calcium by osteo-
blasts in culture8,12,13. It is non-toxic, non mutagenic 
and safe for ingestion after being tested on rats. Padi-
na Pavonica alga has been used as a food in Asian and 
Mediterranean countries for ages13. EPP seems to act 
as a potent phytoestrogen (natural SERM) increasing 
bone density and bone collagen status without visible 
effect on endometrium and vagina in postmenopausal 
women8. Surprisingly EPP amplifies the fixation of 
calcium by osteoblasts even when cultivated in the 
presence of calcium channel inhibitor or interleukine 
1 (IL-1). Calciotropic molecules such as oestradiol, 
calcitonine, vitamin D
3
 and bisphosphonates do not 
demonstrate any activity in osteoblasts cultivated with 
calcium channels inhibitors or IL-1. It seems that the 
active molecules of EPP act independently of the cal-
cium channels12.
Although the effect of marine algae extracts on 
Figure 4. Padina Pavonica (Dictyotales) is one of the most common brown algae of the Mediterranean sea.
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bone metabolism has not yet been clarified, Sargassum 
Horneri (S. horneri), which is obtained from various 
coasts in Japan and China, seems to have an anabolic 
effect on bone calcification in vivo and in vitro. (Fig-
ure 5). This is quite important because research con-
centrates on anabolic agents with proved osteoblastic 
bone formation properties and inhibitory effects on 
osteoblastic bone resorption. S. horneri’s extract has a 
peptide that stimulates bone formation and a polysac-
charide that inhibits bone resorption, thus making it 
an ideal extract for drug development14,15. Notice that 
S. horneri’s extract has no toxicity or mutagenic ef-
fect on rat models. According to experimental data on 
administration of S. horneri extract (10-50 μg/ml) in 
aged rats compared with young rats, there was a sig-
nificant increase in alkaline phosphatase activity, an 
osteoblastic bone formation marker and DNA content, 
which is an index of number of bone cells. It seems 
that S. horneri stimulates osteoblastic bone forma-
tion in aging bone due to its active components15.16. 
Administration of S. horneri’s extract in streptozoto-
cin-diabetic rats prevented diabetes-induced bone loss 
and partially the increase of serum glucose and tri-
glyceride levels with diabetes in vivo9,15. Studies were 
accomplished by using other alga extracts such as U. 
pinattifda, E. bicyclis and C. scmitziana with signif-
icant bone calcium content in rat models but not as 
much as S. horneri’s elevated levels15.
One of the most interesting cases that need to be 
identified the mechanism of action in future studies is 
the extract from Spirulina. It is a blue-green alga, tradi-
tional food for Mexican and African populations with 
•  Hypertension
•  Diabetes, hyperglycemia reduction
•  Anti-mutagenic (e.g. oral carcinoma)








•  Wound healing
•  Anti-hypercholesterolemia (decreasing lipid and triglycerides levels)
•  Bone grafts
•  Cleansing effect in digestive tract
•  Bone calcification
•  Metal poisoning
•  Reinforcement of immune system
•  Sources of vitamins and minerals
•  Improvement of skin elasticity, moisture, firmness
Table 1. Beneficial effects of seaweed for human health.
Figure 5. Sargassum horneri, a marine algae present in 
various coasts in Japan and China.
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positive features such as decreasing serum lipids and 
enhancing the regression of oral carcinoma, antibody 
production e.t.c. A study by Ishimi et al. examined the 
Spirulina intake on osteopenia rat models. There was 
a significant trabecular bone loss under estrogen-defi-
cient and stress-bearing conditions in rodents. There 
was no dependence effect of Spirulina intake on bone 
loss, so the inhibitory effect mechanism is not clear. 
Although many marine algae are rich in minerals and 
growth factors, it is vital to examine each marine alga 
thoroughly for its bone formation properties both in 
vivo and in vitro5. Spirulina is an example of rich in 
micronutrients alga but with bone resorption effects. 
Also epidemiological studies are needed in countries 
that use marine algae as daily food, so as to define 
their effects on aging bone.
Among the latest evolutions in the field of using 
marine alga against osteoporosis is the active absorb-
able algal calcium (AAA Ca). It is produced by heat-
ing (in 800oC) oyster shell and seaweed (Cystophyl-
lum fusiforme) in vacuum, under reduced pressure. 
It is best absorbed from the intestine than any other 
calcium compounds. It efficiently suppresses PTH se-
cretion, increases BMD and decreases vertebral frac-
ture. AAA Ca is used as nutritional supplement with 
success in osteoporotic patients17,18.
Lessons from nature
Phytopharmacology is an enormous chapter of today’s 
modern pharmacology. Natural compounds that are 
extracted from plants are especially important because 
they become the prototype drugs for many newly syn-
thesized compounds. A new area of phytopharma-
cology, marine pharmacology searches the depths of 
the oceans, in order to find compounds with precious 
pharmacological properties. It collaborates with ma-
rine biologists so as to define these substances, iso-
lates and implements them in vitro and in vivo7.
In the past years there was a tremendous research 
in the area of marine pharmacology. Oceans are still 
unexplored with many compounds still unidentified. 
Nevertheless nature offers its gifts to human organism, 
for healing and rehabilating from age-relating diseas-
es such as osteoporosis. Osteoporosis is a progressive 
loss of bone mineral density caused by many factors 
including aging. Aging is a physical process that is 
similar for all organisms. By observation and research 
scientists will be able to identify natural compounds 
from plants (as our ancestors did) for implementing 
novel drugs.
ΠΕΡΙΛΗΨΗ: H θαλάσσια βοτανολογία και η φυτοφαρμακολογία αποτελούν δύο κλάδους που συνεργάζονται στην ανα-
ζήτηση της κατάλληλης θεραπείας για την αντιμετώπιση της οστεοπόρωσης. Τα εκχυλίσματα από θαλάσσια φύκη φαίνεται 
να επιδρούν θετικά στην οστική αναδόμηση και οστεοπόρωση. Είδη όπως η Padiva Pavonica (η οποία μετά από κατάλληλη 
επεξεργασία κυκλοφορεί στο εμπόριο ως συμπλήρωμα διατροφής), η Sargassum Horneri κ.ά. φαίνεται ότι βελτιώνουν τον 
οστικό μεταβολισμό, γιατί είναι πλούσια σε βασικά μέταλλα, αμινοξέα και αυξητικούς παράγοντες. Η έρευνα σε πειραματικά 
μοντέλα ζώων εργαστηρίου με οστεοπενία, έδειξε βελτίωση των βιοχημικών δεικτών του οστικού μεταβολισμού. Παρόλο που 
οι πρώτες ενδείξεις για τις ευεργετικές ιδιότητες των θαλάσσιων φυκών στην οστεοπόρωση προέρχονται από παραδοσιακές 
θεραπείες και παρατηρήσεις σε πληθυσμούς που τα καταναλώνουν επί μακρόν, λίγες είναι οι μελέτες που έχουν γίνει μέχρι 
σήμερα σε κλινικό επίπεδο .
Λέξεις Κλειδιά: SERMs, Φυτοοιστρογόνα, Θαλάσσια φύκη, Ισοφλαβονοειδή, Φυτοφαρμακολογία, Θαλάσσια βοτανολογία, 
Οστικός μεταβολισμός, Οστεοπόρωση, Padina pavonica, Sargassum horneri.
Η δράση των θαλάσσιων φυκών στην οστεοπόρωση.
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